CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 133 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2016. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,329,000 | +80.1% | 11,748 | +59.4% | 0.00% | 0.0% |
| Q1 2017 | $738,000 | -8.6% | 7,370 | -1.9% | 0.00% | 0.0% |
| Q4 2016 | $807,000 | +8.8% | 7,510 | +26.0% | 0.00% | 0.0% |
| Q3 2016 | $742,000 | +22.8% | 5,958 | +4.8% | 0.00% | 0.0% |
| Q2 2016 | $604,000 | -41.1% | 5,685 | -36.5% | 0.00% | 0.0% |
| Q1 2016 | $1,025,000 | -19.9% | 8,959 | -0.2% | 0.00% | 0.0% |
| Q4 2015 | $1,280,000 | +1354.5% | 8,980 | +812.6% | 0.00% | – |
| Q3 2015 | $88,000 | -53.9% | 984 | -40.6% | 0.00% | – |
| Q2 2015 | $191,000 | -23.9% | 1,656 | -36.9% | 0.00% | – |
| Q1 2015 | $251,000 | +93.1% | 2,626 | +35.8% | 0.00% | – |
| Q4 2014 | $130,000 | +103.1% | 1,934 | +62.8% | 0.00% | – |
| Q3 2014 | $64,000 | – | 1,188 | +19700.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 6 | -76.0% | 0.00% | – |
| Q1 2014 | $1,000 | -50.0% | 25 | -67.5% | 0.00% | – |
| Q4 2013 | $2,000 | 0.0% | 77 | +6.9% | 0.00% | – |
| Q2 2013 | $2,000 | – | 72 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Segantii Capital Management Ltd | 50,000 | $5,288,000 | 5.80% |
| RUDMAN ERROL M | 37,001 | $3,934,000 | 3.76% |
| INDUS CAPITAL PARTNERS, LLC | 349,210 | $37,128,000 | 3.60% |
| WARBURG PINCUS LLC | 1,312,200 | $139,513,000 | 3.04% |
| SPQ Asia Capital Ltd | 96,000 | $10,206,000 | 2.63% |
| OBERWEIS ASSET MANAGEMENT INC/ | 82,775 | $8,801,000 | 2.62% |
| Ativo Capital Management LLC | 94,074 | $10,002,000 | 2.44% |
| Sensato Investors LLC | 99,764 | $10,607,000 | 1.72% |
| Cormorant Asset Management, LP | 112,867 | $12,000,000 | 1.70% |
| BARING ASSET MANAGEMENT Ltd | 131,284 | $13,958,000 | 1.14% |